NxStage Outcomes in Spain

The first 86 NxStage users in 12 Spanish dialysis clinics received an adequate dialysis dose, optimal ultrafiltration, improved biochemical markers, and reduced need for antihypertensive drugs, binders, and erythropoietin. Patient and technique survival were both good.

Read the abstract » | (added 2021-09-14)

Tags: Adequate Dialysis Dose, Optimal Ultrafiltration, Biochemical Markers, Antihypertensive Drugs, Binders, Erythropoietin. Patient Survival, Technique Survival